|
KMID : 1009020220200010037
|
|
Clinical Psychopharmacology and Neuroscience
2022 Volume.20 No. 1 p.37 ~ p.50
|
|
|
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
|
|
Woo Young-Sup
Bahk Won-Myong
Seo Jeong-Seok
Park Young-Min
Kim Won
Jeong Jong-Hyun
Shim Se-Hoon
Lee Jung-Goo
Jang Seung-Ho
Yang Chan-Mo
Wang Sheng-Min
|
|
|
Abstract
|
|
|
|
The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) first was published in 2002, and has been revised four times, in 2006, 2012, 2017, and 2021. In this review, we compared recommendations from the recently revised KMAP-DD 2021 to four global clinical practice guidelines (CPGs) for depression published after 2010. The recommendations from the KMAP-DD 2021 were similar to those from other CPGs, although there were some differences. The KMAP-DD 2021 reflected social culture and the healthcare system in Korea and recent evidence about pharmacotherapy for depression, as did other recently published evidence-based guidelines. Despite some intrinsic limitations as an expert consensus-based guideline, the KMAP-DD 2021 can be helpful for Korean psychiatrists making decisions in clinical settings by complementing previously published evidence-based guidelines, especially for some clinical situations lacking evidence from rigorously designed clinical trials.
|
|
|
KEYWORD
|
|
|
Depressive disorder, Pharmacotherapy, Consensus, Guideline, KMAP-DD 2021
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|